1. Home
  2. FOLD vs KMT Comparison

FOLD vs KMT Comparison

Compare FOLD & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$9.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Logo Kennametal Inc.

KMT

Kennametal Inc.

HOLD

Current Price

$27.89

Market Cap

2.1B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
FOLD
KMT
Founded
2002
1938
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.1B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
FOLD
KMT
Price
$9.92
$27.89
Analyst Decision
Buy
Hold
Analyst Count
7
6
Target Price
$30.29
$25.83
AVG Volume (30 Days)
4.6M
829.0K
Earning Date
11-04-2025
11-05-2025
Dividend Yield
N/A
2.85%
EPS Growth
N/A
N/A
EPS
N/A
1.22
Revenue
$598,704,000.00
$1,982,871,000.00
Revenue This Year
$21.12
$2.40
Revenue Next Year
$21.23
$3.62
P/E Ratio
N/A
$23.01
Revenue Growth
21.28
N/A
52 Week Low
$5.51
$17.30
52 Week High
$10.57
$28.76

Technical Indicators

Market Signals
Indicator
FOLD
KMT
Relative Strength Index (RSI) 64.67 68.96
Support Level $9.56 $27.20
Resistance Level $10.05 $28.25
Average True Range (ATR) 0.37 0.71
MACD -0.02 -0.03
Stochastic Oscillator 51.14 87.91

Price Performance

Historical Comparison
FOLD
KMT

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

Share on Social Networks: